| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.7 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |